New regulations requiring OTC medicines imported from the European Union to be re-tested for quality control purposes before sale in the UK will not be introduced from January 2023 as originally planned, according to the UK’s Medicines and Healthcare products Regulatory Agency.
Companies affected will also be given two years notice if anything changes, the regulator adds, and nothing will change until...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?